Knockdown of OTX2 in Medulloblastoma Cell Lines
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Hospital for Sick Children, SickKids Foundation, University of Manitoba, Centre National de la Recherche Scientifique, Université Paris-Saclay, Université Paris Sciences et Lettres, Inserm, Université Paris-Sud, Institut Curie, University of Toronto, Princess Margaret Cancer Centre, University Health Network, Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, McGill Genome Centre, McGill University, Heidelberg University, German Cancer Research Center, Seoul National University Children's Hospital, Children's Memorial Health Institute, Centre de Recherche en Neurosciences de Lyon, Université Claude Bernard Lyon 1, Erasmus MC, Masaryk University, Johns Hopkins Medicine, Johns Hopkins University, Mayo Clinic in Arizona, Fred Hutch Cancer Center, Semmelweis University, Neurological Surgery, University of California, San Francisco, Asan Medical Center, University of Ulsan, Hospital Sant Joan de Déu Barcelona, Chinese University of Hong Kong, University of Pittsburgh, Centro Medico Nacional Siglo XXI, University of Alabama at Birmingham, Virginia Commonwealth University, Osaka National Hospital, University of Colorado Denver, Vanderbilt University Medical Center, Washington University in St. Louis, Kitasato University, Chonnam National University Hwasun Hospital, McMaster University, University of Naples Federico II, Santobono Children's Hospital, Case Western Reserve University, Emory University, Fondazione IRCCS Istituto Nazionale dei Tumori, Universidade de São Paulo, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, St. Jude Children's Research Hospital, University of Calgary, Hôpital Necker-Enfants Malades, Assistance Publique – Hôpitaux de Paris, Carlo Forlanini Hospital, Duke University, University of Geneva, Istituto Giannina Gaslini, Hospital Infantil de México Federico Gómez, Instituto Nacional de Pediatria, UPMC Hillman Cancer Center, Ontario Institute for Cancer Research, University of British Columbia, Discovery Institute, Sanford Burnham Prebys Medical Discovery Institute, McGill University Health Centre, Cedars-Sinai Medical Center
Variable analysis
- OTX2 knockdown using Silencer Select siRNAs 9931 or 9932 (Life Technologies)
- Gene expression changes measured by bulk RNA sequencing (RNAseq)
- Granule neuron differentiation measured by Western blot for RBFOX3 (NeuN)
- Cell lines: HDMB03 and MB3W1 G3 MB cells
- Cell density: 2x10^5 cells/well for bulk RNAseq, 4.5x10^5 cells/well for single-nucleus RNAseq
- Incubation time: 72 hours following transfection
- Negative control: Non-silencing (scramble) siRNA
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!